<DOC>
	<DOCNO>NCT02520414</DOCNO>
	<brief_summary>The purpose study determine safety feasibility use Symphion system office setting .</brief_summary>
	<brief_title>Symphion® System In-Office Study</brief_title>
	<detailed_description>The purpose determine safety feasibility use intrauterine tissue resection system office setting , well expand national discussion regard in-office hysteroscopic procedure relate high standard care cost containment .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>Subjects must meet approved Instructions Use Symphion® bipolar hysteroscopic tissue resection system Confirmation hysteroscopic evaluation access appropriate pathology type size meet Protocol guideline inclusion Subject sign write Informed Consent Subjects pregnant Subjects active genital tract infection ( assessed physician ) Subjects cervical malignancy Subjects previously diagnose endometrial cancer Subjects Type 2 intracavitary myoma Type 0 1 intracavitary myoma great 3.0 cm</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>